60 DEGREES PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
60 Degrees Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q2 2022 to Q3 2024.
  • 60 Degrees Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2024 was $4.33K, a 21% decline year-over-year.
  • 60 Degrees Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2024 was $8.15K.
  • 60 Degrees Pharmaceuticals, Inc. annual Depreciation for 2023 was $21.2K, a 23.5% decline from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.15K $4.33K -$1.15K -21% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $9.3K $1.54K -$5.37K -77.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $14.7K $407 -$6.49K -94.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $21.2K $1.88K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $5.49K -$1.42K -20.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $6.9K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $6.9K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $6.9K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $6.9K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.